Nurix Therapeutics, Inc. (NRIX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Nurix Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.54x | -7.67x | -2.35x | -3.34x | -10.55x | -15.45x |
| P/B Ratio | 2.72x | 2.82x | 1.69x | 1.98x | 3.61x | 2.30x |
| P/S Ratio | 17.45x | 27.21x | 4.39x | 15.59x | 41.55x | 37.49x |
| Profitability | ||||||
| Gross Margin | 77.5% | -306.3% | -145.7% | -377.6% | -291.4% | -273.1% |
| Operating Margin | -340.2% | -390.5% | -201.4% | -476.0% | -396.3% | -364.7% |
| Net Margin | -314.9% | -354.9% | -187.0% | -466.9% | -393.9% | -242.7% |
| EBITDA Margin | -291.5% | -375.8% | -193.4% | -465.3% | -389.6% | -352.4% |
| Liquidity | ||||||
| Current Ratio | 7.02x | 6.46x | 3.40x | 4.51x | 4.70x | 6.70x |
| Quick Ratio | 7.02x | 6.46x | 3.40x | 4.52x | 4.70x | 6.70x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.05x | 0.15x | 0.04x | 0.04x | 0.00x |
YoY = year-over-year change. Source: FMP..